LAZARD ASSET MANAGEMENT LLC

Position in TLRY — Tilray Brands, Inc.

CIK 1207017 NEW YORK, NY

Position in TLRY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,772,270

+$1,678,508 QoQ

Shares Held

394,715

+7182.6% QoQ

Ownership

0.290%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#10

of 233 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LAZARD ASSET MANAGEMENT LLC holds $122,207,057 across 17 Drug Manufacturers - Specialty & Generic names. TLRY ranks #8 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	945,784	$67,964,038
2	RDY	Dr Reddys Laboratories Ltd	1,231,678	$17,847,014
3	NBIX	Neurocrine Biosciences Inc	91,371	$15,399,668
4	KNSA	Kiniksa Pharmaceuticals International, plc	67,291	$4,303,259
5	PAHC	Phibro Animal Health Corp	130,438	$4,095,753
6	LNTH	Lantheus Holdings, Inc.	34,396	$3,815,892
7	ELAN	Elanco Animal Health Inc	95,219	$2,343,339
8	TLRY	Tilray Brands, Inc. This page	394,715	$1,772,270

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,772,270	394,715	+628.3%	Shares	Sole	2026-08-14
2025-09-30	$93,762	54,198	-40.8%	Shares	Sole	2025-11-14
2025-06-30	$37,542	91,568	-55.0%	Shares	Sole	2025-08-14
2024-09-30	$358,255	203,554	+99.3%	Shares	Sole	2024-11-14
2024-06-30	$169,550	102,139	+112.4%	Shares	Sole	2024-08-14
2024-03-31	$118,752	48,078	+473.7%	Shares	Sole	2024-07-09
2022-06-30	$26,148	8,381	0.0%	Shares	Sole	2022-08-09
2022-03-31	$65,120	8,381	0.0%	Shares	Sole	2022-05-13
2021-12-31	$58,918	8,381	0.0%	Shares	Sole	2022-02-09
2021-09-30	$94,621	8,381	0.0%	Shares	Sole	2021-11-15
2021-06-30	$151,528	8,381	—	Shares	Sole	2021-08-12
No filing history on record for this holder in this stock.